Lin LZ, Huang HY, Peng Y, Lin GQ, et al. Preclinical evaluation of a fluorinated bifendate derivative in triple-negative
breast cancer: integrated in vitro and in vivo evidence of antitumor activity. BMC Cancer 2026 Jun 12. doi: 10.1186/s12885-026-16335.
PMID: 42286551
|